• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19.

作者信息

Li Qiuyu, Cui Cheng, Xu Fei, Zhao Jianping, Li Nan, Li Haichao, Wang Tianbing, Zhang Hua, Liu Na, Wei Yudong, Niu Xiaoye, Xu Yan, Dong Jianping, Yao Xueting, Wang Xiaohong, Chen Yahong, Li Haiyan, Song Chunli, Qiao Jie, Liu Dongyang, Shen Ning

机构信息

Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, 100191, China.

Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.

出版信息

Sci China Life Sci. 2021 Apr;64(4):660-663. doi: 10.1007/s11427-020-1871-4. Epub 2021 Jan 18.

DOI:10.1007/s11427-020-1871-4
PMID:33471276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7816738/
Abstract
摘要

相似文献

1
Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19.评估羟氯喹与氯喹相比在中度和重度COVID-19患者中的疗效和安全性。
Sci China Life Sci. 2021 Apr;64(4):660-663. doi: 10.1007/s11427-020-1871-4. Epub 2021 Jan 18.
2
Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency.在 SARS-CoV-2（COVID-19）紧急情况下预防耳毒性。
J Glob Antimicrob Resist. 2020 Dec;23:263-264. doi: 10.1016/j.jgar.2020.09.030. Epub 2020 Oct 17.
3
Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.氯喹和羟氯喹用于治疗新型冠状病毒肺炎的安全性考量
Clin Microbiol Infect. 2020 Sep;26(9):1276-1277. doi: 10.1016/j.cmi.2020.05.006. Epub 2020 May 16.
4
The Rise and Fall of Hydroxychloroquine and Chloroquine in COVID-19.羟氯喹和氯喹在 COVID-19 中的兴衰。
J Pharm Pract. 2022 Dec;35(6):971-978. doi: 10.1177/0897190021997399. Epub 2021 Apr 28.
5
Chloroquine and hydroxychloroquine in covid-19.氯喹和羟氯喹在2019冠状病毒病中的应用
BMJ. 2020 Apr 8;369:m1432. doi: 10.1136/bmj.m1432.
6
Is chloroquine or hydroxychloroquine useful in treating people with COVID-19, or in preventing infection in people who have been exposed to the virus?氯喹或羟氯喹对治疗新型冠状病毒肺炎患者或预防接触过该病毒的人感染是否有效？
Saudi Med J. 2021 Mar;42(3):342-343.
7
Chloroquine drops against SARS-CoV-2 infection.氯喹滴眼液用于对抗新型冠状病毒感染。
Indian J Med Res. 2022 Jan;155(1):215-216. doi: 10.4103/ijmr.ijmr_1303_21.
8
Premature Closure of Scientific Thinking: Deaths Due to Chloroquine and Hydroxychloroquine Used for COVID-19 Infection.科学思维的过早封闭：因用于治疗新冠病毒感染的氯喹和羟氯喹导致的死亡
Am J Ther. 2024;31(2):e186-e187. doi: 10.1097/MJT.0000000000001716.
9
What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology.（羟）氯喹对抗 COVID-19 无效的原因：细胞生物学的见解。
J Mol Cell Biol. 2021 Jul 6;13(3):175-184. doi: 10.1093/jmcb/mjab016.
10
COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help.COVID-19、氯喹再利用和心脏安全问题：手性或许有帮助。
Molecules. 2020 Apr 16;25(8):1834. doi: 10.3390/molecules25081834.

引用本文的文献

1
Drug treatments for mild or moderate covid-19: systematic review and network meta-analysis.轻度或中度新冠肺炎的药物治疗：系统评价与网状Meta分析
BMJ. 2025 May 29;389:e081165. doi: 10.1136/bmj-2024-081165.
2
Ethical review of off-label drugs during the COVID-19 pandemic.2019冠状病毒病大流行期间对超说明书用药的伦理审查
World J Clin Cases. 2022 Jun 16;10(17):5541-5550. doi: 10.12998/wjcc.v10.i17.5541.
3
Discovery of potential anti-SARS-CoV-2 drugs based on large-scale screening in vitro and effect evaluation in vivo.基于大规模体外筛选和体内药效评价发现抗 SARS-CoV-2 药物。
Sci China Life Sci. 2022 Jun;65(6):1181-1197. doi: 10.1007/s11427-021-2031-7. Epub 2021 Dec 24.